Partner

Articles & Insights / Enzyme Formulations

Lactase Products Should Be Specified by Activity as Well as Content

An enzyme can remain physically present after losing catalytic function. Lactase product development therefore needs activity measurements, a defined assay system and evidence that the delivered product retains relevant function during storage and intended use.

Stabicon Life Sciences3 min read

Accreditations, approvals & registrations

  • Prequalified by WHO, Geneva

    One of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

  • Accredited by ISO/IEC 17025:2017 (NABL)

  • Approved by FSSAI

  • Approved by CDSCO, India

  • Facility Registered with FDA, Karnataka

  • Registered with DSIR

  • Registered with AYUSH

All articles

What this article helps you consider

  • Distinguish enzyme mass from activity
  • Match the enzyme to the intended environment
  • Develop an activity assay for the formulation

Distinguish enzyme mass from activity

Protein or ingredient mass does not establish how much lactose a product can hydrolyse. Activity expresses catalytic performance under defined assay conditions. The substrate, pH, temperature and measurement approach form part of the meaning of the reported unit.

USP’s lactase monograph and recognised enzyme-assessment documents demonstrate the use of activity-based descriptions. Different lactase sources and test systems can use different unit definitions. Do not convert between acid lactase units, neutral lactase units or other stated units using an unsupported generic factor. R62R63R64

Match the enzyme to the intended environment

Lactases from different sources can differ in pH behaviour and thermal stability. A product intended to act in milk before consumption faces different conditions from a product intended to be taken with food. Establish the intended use before selecting the enzyme and assay strategy.

An enzyme active in a supplier’s buffered test may perform differently in a finished product or food matrix. Temperature, pH, substrate concentration and contact time influence the reaction. Findings for a specific source or strain should not be extended to all lactases without evidence.

Develop an activity assay for the formulation

A chromogenic substrate can provide a convenient measurement, while a lactose-hydrolysis experiment examines a different practical question. Each approach needs suitable blanks and controls. Ingredients contributing colour, turbidity, glucose or other interfering signals can bias the result.

Verify that reaction time and enzyme concentration remain within a range where the calculation is valid. An endpoint taken after near-complete substrate conversion can conceal activity differences. Quenching and sample timing matter because the enzyme may continue reacting until the test conditions are changed.

Preserve activity during preparation and storage

Extraction conditions can inactivate the enzyme or produce incomplete recovery. Heat, extreme pH, incompatible preservatives and interfacial exposure are potential factors to investigate. A low finished-product result may reflect formulation damage, storage loss or an unsuitable analytical preparation.

The illustration maps ingredient activity, processing retention, storage and delivered portion. In a simplified example, 0.20 g of an ingredient assigned 10,000 activity units per gram contains 2,000 units before any process loss. This is arithmetic using a hypothetical specified assay, not a dose recommendation or a conversion to another activity unit.

Explore the scienceEnzyme Formulations
0.20 g ingredient×10,000 units/g=2,000 units

Before process or storage losses, in one hypothetical specified assay.

ProcessingActivity retained?
StorageActivity stable?
Delivered portionQuantity consistent?

Activity units stay tied to the assay. No conversion between activity-unit systems is implied.

Ingredient activity, process retention, stability and delivered portion jointly determine the activity supplied. Activity units remain tied to the specified assay; no conversion between unit systems is implied.

Evaluate drops and solid formats separately

For drops, activity per millilitre and delivered volume both affect the activity supplied per intended portion. Assess device performance and in-use stability where relevant. A stable concentration cannot compensate for inconsistent dispensing, while a reproducible drop volume cannot compensate for activity loss.

For chewable or solid formats, assess uniformity, processing effects and release under relevant conditions. A total-protein measurement cannot replace activity testing. Conversely, a laboratory activity result does not by itself establish the extent of lactose digestion or symptom relief in every user.

Connect claims to product specific evidence

If a product is intended for pretreatment of a food, define the supported quantity, conditions and contact time through appropriate testing. If it is intended for oral use, assess the evidence and permitted claims for that route and population. Products for infants require specific safety, regulatory and use assessment; evidence from an adult product cannot simply be carried across.

Stabicon can support formulation and activity-testing programmes that keep enzyme identity, assay units, stability and delivered function connected. This provides a clearer basis for specifications and product instructions than ingredient mass alone.

References & further reading

Read the source in its stated scope. Requirements, amendments and compendial editions depend on the product and target market. Draft guidance is identified separately.

  1. R62
    USP Lactase Monograph

    Official publisher preview. Enzyme identity and activity-based description; use the applicable full monograph.

  2. R63
    EFSA Beta Galactosidase from Kluyveromyces Lactis Strain GAL

    Food-enzyme safety assessment, 2022, article 7574. Source-specific activity and assay information.

  3. R64
    EFSA Beta Galactosidase from Aspergillus Oryzae Strain AE LA

    Food-enzyme safety assessment, 2022, article 7569. Source-specific activity and assay information.

  4. R21
    FSSAI Health Supplements and Nutraceuticals Standards

    Official regulations portal. Verify current amendments, permitted ingredients, levels and category-specific requirements.

From insight to a defined programme

Bring your next technical question.

Share your formulation, testing objective or development challenge. Stabicon can review the context and define a suitable scope of work.

Discuss this topic with Stabicon

Continue reading

Related scientific perspectives.

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Request a consent withdrawal at bd@stabicon.com.

Press Kit

Logos, company information & spokesperson details – available from our media team.

Request Press Kit

Accreditations

Prequalified by WHO, GenevaAccredited by ISO/IEC 17025:2017 (NABL)Approved by FSSAIApproved by CDSCO, IndiaFacility Registered with FDA, KarnatakaRegistered with DSIRRegistered with AYUSHOne of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.

Admin